Blueprint Medicines Corp 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Jeffrey W. Albers | 11 | -175,899 |
Christopher K. Murray | 6 | -11,217 |
Michael Landsittel | 4 | -26,744 |
Ariel Hurley | 4 | -7,851 |
Fouad Namouni | 4 | -13,571 |
Kate Haviland | 3 | -18,004 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 0 | 0 |
最近3个月 | 0 | 118,534 | -118,534 |
最近6个月 | 0 | 174,848 | -174,848 |
最近12个月 | 0 | 242,928 | -242,928 |
最近18个月 | 0 | 300,807 | -300,807 |
最近36个月 | 1,100 | 304,817 | -303,717 |
Blueprint Medicines Corp 内部交易
Blueprint Medicines Corp 最新内部交易
Michael Landsittel | CHIEF FINANCIAL OFFICER | 2024-03-28 | 卖出 | 5,000 | 47,286 |
$95
|
+12.83%
|
Jeffrey W. Albers | 董事 | 2024-03-20 | 卖出 | 25,073 | 176,050 |
$87.28
|
+22.81%
|
Michael Landsittel | CHIEF FINANCIAL OFFICER | 2024-03-15 | 卖出 | 13,734 | 47,286 |
$87.78
|
+22.11%
|
Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | 2024-03-15 | 卖出 | 4,549 | 14,913 |
$87.76
|
+22.14%
|
Philina Lee | CHIEF COMMERCIAL OFFICER | 2024-03-13 | 卖出 | 8,023 | 34,729 |
$90.4
|
+18.57%
|
Michael Landsittel | CHIEF FINANCIAL OFFICER | 2024-03-07 | 卖出 | 5,003 | 56,020 |
$90.69
|
+18.19%
|
Christopher K. Murray | CHIEF TECHNICAL OPERATIONS | 2024-03-07 | 卖出 | 2,521 | 33,853 |
$90.69
|
+18.19%
|
Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | 2024-03-07 | 卖出 | 1,462 | 17,862 |
$90.69
|
+18.19%
|
Percy H. Carter | CHIEF SCIENTIFIC OFFICER | 2024-03-07 | 卖出 | 2,286 | 48,331 |
$90.69
|
+18.19%
|
Fouad Namouni | PRESIDENT, R & D | 2024-03-07 | 卖出 | 4,377 | 72,703 |
$90.69
|
+18.19%
|